US Stock MarketDetailed Quotes

JAZZ Jazz Pharmaceuticals

Watchlist
  • 111.170
  • -7.020-5.94%
Close May 6 16:00 ET
  • 106.950
  • -4.220-3.80%
Pre 04:58 ET
6.85BMarket Cap15.10P/E (TTM)

Jazz Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
27.83%1.4B
138.19%398.58M
29.80%398.75M
11.65%331.35M
-16.68%267.23M
-14.15%1.09B
-51.07%167.34M
-26.51%307.2M
-2.07%296.77M
Net income from continuing operations
----
35.02%560.12M
102.98%191.12M
46.48%215.06M
61.40%168.57M
-121.06%-14.62M
285.14%414.83M
139.11%94.15M
847.25%146.82M
201.28%104.44M
Depreciation and amortization
----
3.35%660.07M
5.79%168.42M
1.64%165.23M
2.17%163.04M
3.83%163.38M
1.47%638.7M
10.00%159.2M
9.23%162.56M
2.16%159.58M
Deferred tax
----
19.94%-208.33M
93.44%-2.36M
18.40%-64.4M
5.23%-75.18M
-0.49%-66.39M
10.96%-260.22M
75.31%-35.9M
-22.25%-78.92M
-114.56%-79.33M
Other non cash items
----
-9.41%184.97M
189.56%39.25M
8.88%46.81M
-39.19%39.3M
-28.18%59.61M
-72.45%204.17M
-97.07%13.56M
-51.13%42.99M
-49.75%64.62M
Change In working capital
----
62.47%-76.72M
55.84%-79.93M
-7.47%-26.38M
-55.79%-26.81M
207.79%56.4M
-2,164.00%-204.44M
-407.70%-181.01M
-135.21%-24.55M
77.92%-17.21M
-Change in receivables
----
59.30%-21.12M
101.14%864K
-18.02%-22.26M
-37.62%8.72M
-129.67%-8.44M
42.44%-51.88M
-63.11%-75.46M
-95.68%-18.86M
157.04%13.98M
-Change in inventory
----
-239.36%-45.54M
-1,229.42%-18.67M
-88.20%-9.29M
-481.74%-4.75M
-104.98%-12.84M
72.97%-13.42M
-272.06%-1.4M
42.15%-4.93M
95.23%-816K
-Change in prepaid assets
----
108.38%10.57M
111.10%9.87M
-0.67%-34.16M
55.81%-20.08M
30.73%54.95M
-452.57%-126.18M
-841.24%-88.85M
-3,058.59%-33.94M
-8,703.10%-45.42M
-Change in payables and accrued expense
----
343.46%51.34M
-191.86%-8.24M
3.31%40.3M
-1,314.60%-10.65M
180.29%29.94M
-92.44%11.58M
-93.16%8.98M
-59.17%39.01M
102.22%877K
-Change in other current assets
----
-3,394.55%-32.71M
-713.22%-33.86M
93.23%-347K
-49.04%1.89M
92.31%-387K
89.90%-936K
134.65%5.52M
-9,257.14%-5.13M
46.02%3.7M
-Change in other current liabilities
----
-69.74%-39.27M
-0.37%-29.89M
10.50%-631K
-118.51%-1.94M
-118.02%-6.81M
16.83%-23.14M
-32.68%-29.78M
91.56%-705K
494.44%10.47M
-Change in other working capital
----
----
----
----
----
----
77.88%-463K
99.24%-4K
--0
--0
Cash from discontinued investing activities
Operating cash flow
60.83%429.78M
27.83%1.4B
138.19%398.58M
29.80%398.75M
11.65%331.35M
-16.68%267.23M
-14.15%1.09B
-51.07%167.34M
-26.51%307.2M
-2.07%296.77M
Investing cash flow
Cash flow from continuing investing activities
-211.66%-508.2M
-289.87%-193.29M
222.83%214.09M
-199.85%-257.09M
-5,538.82%-271.9M
63.46%-163.06M
131.38%101.8M
-3,887.46%-174.3M
3.84%-85.74M
Net PPE purchase and sale
----
-58.88%-38.07M
-31.53%-13.29M
-150.94%-10.79M
-23.56%-7.09M
-80.64%-6.9M
17.50%-23.96M
-7.72%-10.1M
-187.70%-4.3M
53.26%-5.74M
Net intangibles purchase and sale
----
47.37%-10M
--0
--0
--0
-900.00%-10M
95.95%-19M
95.20%-18M
--0
--0
Net business purchase and sale
----
--0
----
----
----
----
--0
----
----
----
Net investment purchase and sale
----
-283.12%-460.13M
-238.57%-180M
232.28%224.88M
-212.50%-250M
---255M
-11,492.66%-120.1M
116.50%129.9M
-56,566.67%-170M
---80M
Cash from discontinued investing activities
Investing cash flow
37.87%-168.93M
-211.66%-508.2M
-289.87%-193.29M
222.83%214.09M
-199.85%-257.09M
-5,538.82%-271.9M
63.46%-163.06M
131.38%101.8M
-3,887.46%-174.3M
3.84%-85.74M
Financing cash flow
Cash flow from continuing financing activities
106.72%20.52M
91.75%-8.28M
413.95%246.43M
-66.64%-161.09M
-89.85%-56.55M
42.35%-305.25M
-611.87%-100.31M
72.84%-78.49M
-996.98%-96.67M
Net issuance payments of debt
----
1,308.93%374.77M
0.00%-7.75M
5,235.70%398.02M
0.00%-7.75M
0.00%-7.75M
94.67%-31M
0.00%-7.75M
97.48%-7.75M
0.05%-7.75M
Net common stock issuance
----
-15.45%-311.43M
--0
-101.69%-150M
----
----
-499,457.41%-269.76M
---99.8M
---74.37M
----
Proceeds from stock option exercised by employees
----
-55.56%20.65M
3.87%9.2M
-99.69%17K
0.68%10.94M
-97.67%494K
-52.60%46.46M
-70.64%8.85M
-74.07%5.51M
-56.32%10.87M
Net other financing activities
----
-24.57%-63.47M
-502.29%-9.72M
14.81%-1.61M
32.02%-2.85M
-13.94%-49.3M
-12.12%-50.95M
42.58%-1.61M
26.61%-1.88M
33.41%-4.19M
Cash from discontinued financing activities
Financing cash flow
-1,338.44%-813.47M
106.72%20.52M
91.75%-8.28M
413.95%246.43M
-66.64%-161.09M
-89.85%-56.55M
42.35%-305.25M
-611.87%-100.31M
72.84%-78.49M
-996.98%-96.67M
Net cash flow
Beginning cash position
----
70.88%1.51B
66.07%2.22B
5.73%1.36B
23.59%1.44B
70.88%1.51B
49.04%881.48M
59.13%1.34B
80.28%1.28B
137.94%1.17B
Current changes in cash
----
45.62%908.23M
16.70%197.02M
1,479.44%859.26M
-175.92%-86.82M
-121.40%-61.23M
110.52%623.69M
353.98%168.83M
-59.26%54.4M
-49.09%114.36M
Effect of exchange rate changes
199.82%1.7M
-247.32%-1.68M
-227.95%-2.29M
401.97%3.07M
-2,332.35%-759K
-612.99%-1.7M
118.27%1.14M
-63.75%1.79M
81.33%-1.02M
100.81%34K
End cash Position
----
60.18%2.41B
60.18%2.41B
66.07%2.22B
5.73%1.36B
23.59%1.44B
70.88%1.51B
70.88%1.51B
59.13%1.34B
80.28%1.28B
Free cash flow
71.69%429.78M
28.48%1.35B
176.72%385.29M
28.08%387.96M
11.42%324.26M
-20.75%250.33M
35.57%1.05B
428.33%139.24M
-28.38%302.9M
31.32%291.03M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 27.83%1.4B138.19%398.58M29.80%398.75M11.65%331.35M-16.68%267.23M-14.15%1.09B-51.07%167.34M-26.51%307.2M-2.07%296.77M
Net income from continuing operations ----35.02%560.12M102.98%191.12M46.48%215.06M61.40%168.57M-121.06%-14.62M285.14%414.83M139.11%94.15M847.25%146.82M201.28%104.44M
Depreciation and amortization ----3.35%660.07M5.79%168.42M1.64%165.23M2.17%163.04M3.83%163.38M1.47%638.7M10.00%159.2M9.23%162.56M2.16%159.58M
Deferred tax ----19.94%-208.33M93.44%-2.36M18.40%-64.4M5.23%-75.18M-0.49%-66.39M10.96%-260.22M75.31%-35.9M-22.25%-78.92M-114.56%-79.33M
Other non cash items -----9.41%184.97M189.56%39.25M8.88%46.81M-39.19%39.3M-28.18%59.61M-72.45%204.17M-97.07%13.56M-51.13%42.99M-49.75%64.62M
Change In working capital ----62.47%-76.72M55.84%-79.93M-7.47%-26.38M-55.79%-26.81M207.79%56.4M-2,164.00%-204.44M-407.70%-181.01M-135.21%-24.55M77.92%-17.21M
-Change in receivables ----59.30%-21.12M101.14%864K-18.02%-22.26M-37.62%8.72M-129.67%-8.44M42.44%-51.88M-63.11%-75.46M-95.68%-18.86M157.04%13.98M
-Change in inventory -----239.36%-45.54M-1,229.42%-18.67M-88.20%-9.29M-481.74%-4.75M-104.98%-12.84M72.97%-13.42M-272.06%-1.4M42.15%-4.93M95.23%-816K
-Change in prepaid assets ----108.38%10.57M111.10%9.87M-0.67%-34.16M55.81%-20.08M30.73%54.95M-452.57%-126.18M-841.24%-88.85M-3,058.59%-33.94M-8,703.10%-45.42M
-Change in payables and accrued expense ----343.46%51.34M-191.86%-8.24M3.31%40.3M-1,314.60%-10.65M180.29%29.94M-92.44%11.58M-93.16%8.98M-59.17%39.01M102.22%877K
-Change in other current assets -----3,394.55%-32.71M-713.22%-33.86M93.23%-347K-49.04%1.89M92.31%-387K89.90%-936K134.65%5.52M-9,257.14%-5.13M46.02%3.7M
-Change in other current liabilities -----69.74%-39.27M-0.37%-29.89M10.50%-631K-118.51%-1.94M-118.02%-6.81M16.83%-23.14M-32.68%-29.78M91.56%-705K494.44%10.47M
-Change in other working capital ------------------------77.88%-463K99.24%-4K--0--0
Cash from discontinued investing activities
Operating cash flow 60.83%429.78M27.83%1.4B138.19%398.58M29.80%398.75M11.65%331.35M-16.68%267.23M-14.15%1.09B-51.07%167.34M-26.51%307.2M-2.07%296.77M
Investing cash flow
Cash flow from continuing investing activities -211.66%-508.2M-289.87%-193.29M222.83%214.09M-199.85%-257.09M-5,538.82%-271.9M63.46%-163.06M131.38%101.8M-3,887.46%-174.3M3.84%-85.74M
Net PPE purchase and sale -----58.88%-38.07M-31.53%-13.29M-150.94%-10.79M-23.56%-7.09M-80.64%-6.9M17.50%-23.96M-7.72%-10.1M-187.70%-4.3M53.26%-5.74M
Net intangibles purchase and sale ----47.37%-10M--0--0--0-900.00%-10M95.95%-19M95.20%-18M--0--0
Net business purchase and sale ------0------------------0------------
Net investment purchase and sale -----283.12%-460.13M-238.57%-180M232.28%224.88M-212.50%-250M---255M-11,492.66%-120.1M116.50%129.9M-56,566.67%-170M---80M
Cash from discontinued investing activities
Investing cash flow 37.87%-168.93M-211.66%-508.2M-289.87%-193.29M222.83%214.09M-199.85%-257.09M-5,538.82%-271.9M63.46%-163.06M131.38%101.8M-3,887.46%-174.3M3.84%-85.74M
Financing cash flow
Cash flow from continuing financing activities 106.72%20.52M91.75%-8.28M413.95%246.43M-66.64%-161.09M-89.85%-56.55M42.35%-305.25M-611.87%-100.31M72.84%-78.49M-996.98%-96.67M
Net issuance payments of debt ----1,308.93%374.77M0.00%-7.75M5,235.70%398.02M0.00%-7.75M0.00%-7.75M94.67%-31M0.00%-7.75M97.48%-7.75M0.05%-7.75M
Net common stock issuance -----15.45%-311.43M--0-101.69%-150M---------499,457.41%-269.76M---99.8M---74.37M----
Proceeds from stock option exercised by employees -----55.56%20.65M3.87%9.2M-99.69%17K0.68%10.94M-97.67%494K-52.60%46.46M-70.64%8.85M-74.07%5.51M-56.32%10.87M
Net other financing activities -----24.57%-63.47M-502.29%-9.72M14.81%-1.61M32.02%-2.85M-13.94%-49.3M-12.12%-50.95M42.58%-1.61M26.61%-1.88M33.41%-4.19M
Cash from discontinued financing activities
Financing cash flow -1,338.44%-813.47M106.72%20.52M91.75%-8.28M413.95%246.43M-66.64%-161.09M-89.85%-56.55M42.35%-305.25M-611.87%-100.31M72.84%-78.49M-996.98%-96.67M
Net cash flow
Beginning cash position ----70.88%1.51B66.07%2.22B5.73%1.36B23.59%1.44B70.88%1.51B49.04%881.48M59.13%1.34B80.28%1.28B137.94%1.17B
Current changes in cash ----45.62%908.23M16.70%197.02M1,479.44%859.26M-175.92%-86.82M-121.40%-61.23M110.52%623.69M353.98%168.83M-59.26%54.4M-49.09%114.36M
Effect of exchange rate changes 199.82%1.7M-247.32%-1.68M-227.95%-2.29M401.97%3.07M-2,332.35%-759K-612.99%-1.7M118.27%1.14M-63.75%1.79M81.33%-1.02M100.81%34K
End cash Position ----60.18%2.41B60.18%2.41B66.07%2.22B5.73%1.36B23.59%1.44B70.88%1.51B70.88%1.51B59.13%1.34B80.28%1.28B
Free cash flow 71.69%429.78M28.48%1.35B176.72%385.29M28.08%387.96M11.42%324.26M-20.75%250.33M35.57%1.05B428.33%139.24M-28.38%302.9M31.32%291.03M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
JINGHAO MEDICAL
872925
+29.96%
TONGYI AEROSPACE
871642
+25.11%
ESKONJAC
839273
+21.20%
4
Jiangsu Olive Sensors High-Tech
300507
+20.05%
5
Jing-Jin Electric Technologies
688280
+20.05%
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.